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Background: Severe malaria may influence inner ear function, although this possibility has not been examined
prospectively. In a retrospective analysis, hearing impairment was found in 9 of 23 patients with cerebral malaria.
An objective method to quickly evaluate the function of the inner ear are the otoacoustic emissions. Negative
transient otoacoustic emissions are associated with a threshold shift of 20 dB and above.
Methods: This prospective multicenter study analyses otoacoustic emissions in patients with severe malaria up to
the age of 10 years. In three study sites (Ghana, Gabon, Kenya) 144 patients with severe malaria and 108 control
children were included. All malaria patients were treated with parental artesunate.
Results: In the control group, 92.6 % (n = 108, 95 % confidence interval 86.19–6.2 %) passed otoacoustic emission
screening. In malaria patients, 58.5 % (n = 94, malaria vs controls p < 0.001, 95 % confidence interval 48.4–67.9 %)
passed otoacoustic emission screening at the baseline measurement. The value increased to 65.2 % (n = 66,
p < 0.001, 95 % confidence interval 53.1–75.5 %) at follow up 14–28 days after diagnosis of malaria.
The study population was divided into severe non-cerebral malaria and severe malaria with neurological symptoms
(cerebral malaria). Whereas otoacoustic emissions in severe malaria improved to a passing percentage of 72.9 %
(n = 48, 95 % confidence interval 59–83.4 %) at follow-up, the patients with cerebral malaria showed a drop in
the passing percentage to 33 % (n = 18) 3–7 days after diagnosis. This shows a significant impairment in the
cerebral malaria group (p = 0.012 at days 3–7, 95 % confidence interval 16.3–56.3 %; p = 0.031 at day 14–28, 95 %
confidence interval 24.5–66.3 %).
Conclusion: The presented data show that 40 % of children have involvement of the inner ear early in severe
malaria. In children, audiological screening after severe malaria infection is not currently recommended, but is
worth investigating in larger studies.
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With more than three billion humans at risk of malaria
and more than 240 million cases per year worldwide,
malaria is one of the most common infectious diseases
[1]. Hearing loss affects approximately 278 million people
worldwide [2] with approximately two thirds living in
resource-poor countries. The high prevalence of hearing
impairment in these countries is partly explained by lack
of immunization and medical care as well as inadequate
funds for intervention once hearing loss has been identi-
fied [2]. Hearing impairment associated with malaria has
been observed over the past century and has been attrib-
uted to the side effects of antimalarials, like quinine [3],
chloroquine [4], mefloquine [5], and artemisinin derivates
[6, 7]. In an artemisinin combination therapy trial in chil-
dren aged 0.5–-14 years, uncomplicated malaria has been
suspected to be the cause of elevated hearing thresholds.
Prior to therapy, hearing thresholds in children with mal-
aria were significantly higher than those seen in the con-
trol group [8]. Carter et al. suspected severe malaria to be
a cause of acquired language disorders [9]. In children,
hearing impairment is one of the fundamental causes of
language and developmental disorders. Nine out of 23
children with cerebral malaria had impaired hearing in
addition to other neurological and cognitive sequelae [10].
So far, no prospective study evaluating hearing with ob-
jective tests has been performed for severe malaria.
In a murine model, severe malaria causes significant
hearing impairment [11]. Histomorphology revealed an
induction of apoptosis in the fibrocytes of the spiral liga-
ment and a breakdown of the blood labyrinth barrier
[12, 13]. Both structures are essential to maintain the
endocochlear potential, which drives the function of the
inner and outer hair cells. The inner hair cells generate
the action potential, which contains the hearing informa-
tion. The outer hair cells are responsible for local ampli-
fication of the sound in the cochlea. The contraction of
these cells can be measured as otoacoustic emissions
(OAE) in the outer ear canal [14].
OAE testing is a specific objective hearing test, which
has been used in neonatal hearing screening programs.
The presence of OAE confirms a regular function of the
inner ear. In transient OAE testing, a click stimulus is
applied to the outer ear canal. This stimulus provokes a
contraction of the outer hair cells in the inner ear, which
can be detected afterwards in the outer ear canal. Tran-
sient OAE is generally evaluated as the cross-correlation
or “wave reproducibility” of multiple measurements.
Wave reproducibility is expressed as a ratio from –100
% to +100 %. A high cross-correlation or wave reprodu-
cibility is generally accepted as a measure of normal
hearing [15]. Reproducibility of 60 % or below is consid-
ered a failed test or impaired hearing. Failed OAE are as-
sociated with a hearing impairment of 20 dB or moreand require further audiological testing [16]. Transient
OAE show a sensitivity of 93 % and a specificity of 67 %
in detecting a hearing loss of 30 dB or more [17].
The goal of this prospective multicenter study was to
evaluate the inner ear function of children with severe
malaria by using transitory evoked OAE and assessing
the proportion of children who failed OAE examination.
Materials and methods
The present study was performed as a sub-study of “Se-
vere Malaria in African Children II” (SMAC) (registered
at PACTR201102000277177). The study and the sub-
study have been approved by the local ethic committees
in Kumasi, Ghana; Kisumu, Kenya; and Lambaréné,
Gabon. The studies have been performed in three study
sites: Komfo Anokye Teaching Hospital, Kumasi, Ghana;
Centre de Recherche Mèdicale de Lambaréné, Lambar-
éné, Gabon; and Kenya Medical Research Institute, Ki-
sumu, Kenya. Guardian informed consent was obtained
from all participants.
Study design
The study was designed as a prospective multicenter co-
hort study, comparing OAE measured in children with
severe malaria to a healthy, local, age-matched control
population. The malaria cohort was divided into a severe
malaria group and a cerebral malaria group. OAE were
measured in the control group once. In the malaria
groups they were measured at the following time points:
immediately after diagnosis of severe malaria prior to
starting medication, 12–24 h after the first medication,
after recovery, 3–7 days post diagnosis, and 14–28 days
after the diagnosis. OAE were considered as absent if
the reproducibility was below 60 %.
Cohort selection
The healthy control population was recruited at the
study sites outside the hospital in schools and kindergar-
tens. Children aged up to 10 years with no medical his-
tory of hearing impairment and no history of fevere
related admission to hospital as an in-patient qualified
for the control group [18]. No further clinical or labora-
tory examination was performed.
The severe malaria group was selected according to
the following parameters: children up to 10 years; a diag-
nosis of Plasmodium falciparum malaria confirmed with
a minimum parasitemia of >5000 parasites/μL on the
initial blood smear; asexual forms of P. falciparum; and
clinical manifestations that required hospitalization, like
hyperlactatemia or metabolic acidosis, severe anemia,
dark urine, hypoglycemia, jaundice, respiratory distress,
severe vomiting, shock, abnormal bleeding, and/or renal
failure [19–21]. Antimalarial treatment within 24 h prior
to admission was an exclusion criterion.
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neurological signs and symptoms like coma with a Blan-
tyre Coma score of ≤ 2, repeated generalized seizures,
focal neurological findings, or prostration [21]. Prostra-
tion was defined by the presence of one or more of the
following symptoms: not being able to breastfeed, sit,
stand, or walk depending on the age of the child [20].
Fundoscopy was not done.
For all groups, the ear inspection had to show a trans-
parent tympanic membrane. Children with pathologic
findings in the ear canal did not qualify. The baseline
OAE testing was done immediately after confirmation of
severe or cerebral malaria.
Further clinical and laboratory examinations were per-
formed in the severe malaria and the cerebral malaria
group at the time of inclusion in the study. On admis-
sion the vital signs—heart rate, temperature, respiratory
rate—were documented. The following clinical and la-
boratory parameters were examined: respiratory distress,
deep breathing, severe vomiting, prostration, coma,
repeated generalized seizures, jaundice, parasitemia,
hemoglobin, platelets, glucose, creatinine, alaninamino-
transferase, bilirubin, glucose, hemoglobinuria.Malaria therapy
As part of the SMAC II study, all patients were treated
with parenteral artesunate after the first baseline meas-
urement. The total dose of artesunate was 12 mg/kg,
given as five intramuscular injections of 2.4 mg/kg at 0,
12, 24, 48, and 72 h or as three injections of 4 mg/kg at
0, 24, and 48 h either intramuscularly or intravenously.
Allocation to one of the three schedules was random.
Upon discharge patients received a weight-adapted
standard regimen of artemether and lumefantrine [22].Otoacoustic emissions measurement
The OAE measurements were performed at each study
site by two operators. Transient OAE were measured
using a Madsen Capella Otoacoustic emissions machine
(Otometric, Taastup, Denmark). Both ears were mea-
sured five times and the best result was taken. If the
reproducibility was below 60 % on one ear the OAE
were considered absent. Each measurement consisted
of 2080 repetitions. A broadband click ranging from 1
kHz to 4 kHz for 2 ms was used as a stimulus. The
measurement was considered of a poor quality if the re-
jection rate exceeded more than 2000 sweeps. There-
fore measurements were excluded with more than 2000
rejected sweeps. If the measurement at baseline did not
work, the OAE testing was abandoned, and the treat-
ment of the severely sick child immediately initiated. A
second try was performed at the other measurement
time points.Statistical evaluation
Otoacoustic measurements with a reproducibility below
60 % on one ear or both ears were considered a fail.
Demographic and clinical data were compared between
groups depending on data type and distribution either
by Student’s t-test or Mann–Whitney U test for continu-
ous variables and by chi-square test or Fisher’s exact test
for proportions as appropriate. The proportions of pa-
tients passing the OAE test were compared between
groups (malaria vs control or the different treatment
regimens respectively) by chi-square test. The study col-
lective was categorized into severe non-cerebral malaria
and cerebral malaria and statistically compared as de-
scribed above. In order to identify prognostic factors for
failing the OAE test at last follow-up, a univariate com-
parison of admission data was done between patients
failing and patients passing on the last follow-up as de-
scribed above. Variables with association at a signifi-
cance level of p < 0.05 in the univariate analysis were
entered into a stepwise logistic regression model with
conditional forward selection as the selection method
and age and sex as mandatory variables. The statistical




For the malaria group, 144 patients were recruited and
108 children as controls. Not all patients could be re-
cruited for every measurement, partly because of prior
administration of the study medication (baseline, 53 pa-
tients), or the patient being absolutely uncooperative
(12–24 h, 26 patients, 3–7 days, 20 patients; 14–28 days,
14 patients), or due to loss to follow-up (3–7 days, 12
patients; 14–28 days, 64 patients). No death was to be
reported in the study population. The malaria group
consisted of 67 female and 73 male patients (four were
not documented), the sex distribution in the control
group was 50 female and 56 male (two were not docu-
mented), with no significant difference in the sex distri-
bution (p = 0.898). The mean age in the malaria group
was 3.43 years (SD 2.384) and in the control group 3.82
years (SD 2.506).
Detailed clinical data for the malaria groups are listed
in Table 1. The overall proportion of passes in the con-
trol group was 92.6 %. At the baseline measurement only
58 % (p < 0.001, 95 % confidence interval (CI), 48.4–67.9
%) of all malaria patients passed the OAE testing. The
results of the OAE are listed in Fig. 1. At 12–24 h after
prior medication, the overall passing percentage in-
creased to 61 % (95 % CI, 52–69.3 %) with p < 0.001
compared to the control group (Fig. 1). At the third
measurement time point, 3–7 days after primary medi-
cation, the passing percentage was 59.8 % (95 % CI,
Table 1 Clinical data
Parameter units Severe malaria Cerebral malaria p-value
Result Mean (SD) Result Mean (SD) Severe malaria vs cerebral malaria
Parasitemia Parasites/μl 114 97,111 (1,271,985) 24 139,743 (683,264) NSd
Pulse /min 120 126 (22) 24 132 (21) NSc
Temperature Celsius 120 38.3 (1.24) 24 37.9 (1.17) NSc
Respiratory rate /min 120 37.1 (11.5) 24 42.9 (12.3) 0.027c
Hemoglobin g/dl 119 8.7 (2.3) 24 8.3 (2.7) NSc
Platelets 1000/ μl 119 109.310 (94.924) 24 67.458 (50.113) 0.016d
White blood cells 1000 /μl 119 9.7 (6.7) 24 10.2 (4.1) NSd
Glucose mmol/l 98 5.169 (2.342) 20 4.895 (2.521) NSc
Creatinine g/l 96 23.5 (91)b 18 31.5 (568)b NSd
Bilirubin g/l 99 27.5 (184)b 21 29 (77)b NSd
ALT U/l 101 32.2 (33.4) 20 34.9 (26.9) NSd
Hemoglobinuria % of included patients 119 1.7 % 24 4.2 % NSe
Respiratory distress % of included patients 119 4.2 % 24 12.5 % NSf
Deep breathing % of included patients 120 1.7 % 24 0 % NSf
Severe vomiting % of included patients 119 2.5 % 24 4.2 % NSf
Prostration % of included patients 119 16.8 % 24 54.2 % 0.000f
Coma % of included patients 119 0 % 24 37.5 % 0.000f
Repeated generalized seizures % of included patients 119 0 % 24 50 % 0.000f
Jaundice % of included patients 119 4.2 % 24 12.5 % NSf
Severe anemia % of included patients 119 10.1 % 24 20.8 % NSe
Hypoglycemia % of included patients 119 2.5 % 24 8.3 % 0.03e
The results of the evaluated clinical data are listed for patients with severe malaria and with cerebral malaria
Mean and standard deviation are given for continuous variables; comparison between groups has been performed by the indicated tests. NS, not significant
aGeometric mean (range); bmedian (range); cStudents t-test; dMann–Whitney U test; echi-square test; fFisher’s exact test
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14 to 28 days after inclusion to the study, the average
proportion passing was 65.2 % (95 % CI, 53.1–75.5 %) in
the malaria group, showing a statistically significant dif-
ference at p < 0.001 to the healthy control group. No
statistical difference of the OAE could be detected be-
tween the three different artemether and lumefantrine
therapy regimes.
There was no difference in baseline OAE pass rate be-
tween the severe malaria without neurological symptoms
group and the cerebral malaria group (severe malaria 58
%, 95 % CI, 47.2–68.2 %; cerebral malaria 61.5 %, 95 %
CI, 35.5–82.3 %). Within 12 to 24 h, the passing percent-
age dropped slightly in the cerebral malaria group to
52.9 % (95 % CI, 31–73.8 %) in contrast to a slightly im-
proved passing percentage of 62.4 % (95 % CI, 52.6–71.2
%) in the severe malaria population. The gap further in-
creased at the 3–7 day measurement to a statistical sig-
nificant value (severe malaria 64.9 %, 95 % CI, 54.8–73.8
%; cerebral malaria 33.3 %, 95 % CI 16.3–56.3 %; p =
0.012). A further significant difference was observed at
the follow-up 14–28 days after inclusion (severe malaria72.9 %, 95 % CI, 59–83.4 %; cerebral malaria 44 %, 95 %
CI, 24.6–66.3 %) (Fig. 1).
Prognostic factors for hearing impairment on last
follow-up
To identify prognostic factors for hearing impairment at
the last follow-up, important demographic, clinical, and
laboratory variables were compared between patients
passing or failing the last OAE measurement. Reticulo-
cyte count, height, respiratory distress, repeated general-
ized seizures, and severity group (severe malaria vs
cerebral malaria) were associated with hearing impair-
ment at last follow-up. These variables were entered into
a stepwise binary logistic regression model with age and
sex as mandatory predictors. In this model the signifi-
cant predictors associated with hearing impairment were
age and the malaria severity group. Younger children
had a significantly higher risk of hearing impairment
(Table 2). Children with cerebral malaria had a 5.09-fold
(95 % CI, 1.25–20.77) increased risk for hearing impair-
ment compared to children with severe non-cerebral
malaria (Table 2).
Fig. 1 Passing proportions of the OAE. The proportion of passing individuals is shown for the four included groups in the y-axis (control group,
all malaria patients, severe malaria without neurological symptoms, cerebral malaria). The x-axis shows the different measurement time points.
The number of included patients for each group is added in the labeling of the x-axis. The filled symbols indicate the proportion of passing
individuals in each group. The blank symbols indicate which figures have been compared for the p-values included in the figure
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The present study shows that severe non-cerebral and
cerebral malaria [23] may lead to a significant impair-
ment of the inner ear function in the acute stage of the
disease. Through the course of the disease the OAE
improved in the severe malaria group, whereas there
was further impairment of the OAE in the cerebral
malaria group.
The control group was recruited outside the hospital
with no admission to hospital as an in-patient for fever.
Hospitalization for fever had been shown to be associ-
ated with significant hearing impairment in sub-SaharanTable 2 Binary logistic regression model
Significance Odd’s ratio Confidence interval
Lower Upper
Male sex 0.302 2.001 0.536 7.466
Age 0.014 0.728 0.566 0.938
Cerebral malaria 0.023 5.089 1.247 20.771
The results of the stepwise binary logistic regression model are shown, with
hearing impairment at the last follow-up as the outcome variableAfrica [18]. The malaria group and the control group
were well balanced, showing no significant differences
for age and sex.
In the control group 92.6 % of the evaluated children
passed the otoacoustic testing, indicating a functioning
inner ear. An evaluation of preschool children per-
formed in the US showed a similar passing percentage
of 91 % in a group comparable for age and sex [24].
In the malaria group the evaluated passing percentage
started at 58.5 % at the baseline measurement and
increased to 65.2 % at the follow-up 14–28 days after
diagnosis, showing highly significant differences. This
finding indicates that severe malaria affects the inner ear
in 40 % of cases. Transient OAE are absent at a cochlea
with hearing loss of 20 dB or more [16]. Similar thresh-
old shifts have recently been reported in uncomplicated
malaria by Adjei et al. [8]. Interestingly, the percentage
of failures increased through the course of the disease in
the cerebral malaria group and decreased in the severe
non-cerebral malaria group, showing significant differ-
ences at day 3–7 and day 14–28, suggesting that cerebral
malaria is more likely to influence cochlear function
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sion model further supported this observation. Children
with cerebral malaria showed a 5.09-fold higher risk of
OAE failure than children with severe non-cerebral mal-
aria. This observation is supported by a murine malaria
study, which showed higher threshold shifts in the cere-
bral malaria mice and lower threshold shifts in animals
with no neurologic symptoms [11].
Cerebral malaria is known to influence the blood–
brain barrier [25]. Similar disturbance of the blood laby-
rinth barrier has been observed in an animal model of
cerebral malaria [12]. These pathologic alterations can
possibly explain the observed course of the transient
OAE. Furthermore, the stepwise binary regression model
revealed age as a significant factor for hearing loss.
Younger children were more likely to fail transient OAE.
This observation can be linked to the fact that young
age is a known risk factor for hyperparasitemia with an
increased risk of progression to cerebral malaria [26].
Artemisinin ototoxicity has been discussed in various
studies with divergent interpretation [7]. Toovey et al.
examined the hearing of 150 construction workers
with malaria in Mozambique, who were treated with
artemisinin-based combination therapies (ACTs). The
control group were healthy people without malaria and
no ACT treatment. The conclusion of this study was
that ACT leads to hearing impairment [27]. Hutagalung
et al. performed a comparable study using a malaria-
exposed population as control. This study did not reveal
any hearing impairment [28]. At the time, their data was
interpreted without the knowledge that malaria itself
leads to hearing impairment in animal models [11]. Our
results suggest that artemisinin does not influence inner
ear function in patients with severe malaria, because the
recorded otoacoustic impairment was present prior to
the first treatment and did gradually improve. Further-
more, the therapy regimes of artemether and lumefan-
trine were not associated with the otoacoustic emission
results. An ototoxic effect of artemisinin would have re-
sulted in a further decrease of the passing percentage.
The statistical evaluation showed a significant associ-
ation with hearing loss of the following parameters:
reticulocyte count, respiratory distress, height, and re-
peated generalized seizures. Patients with a high count
of reticulocytes showed less inner ear impairment than
patients with a low count of reticulocytes. This can be
explained by the fact that the “anemic malaria” results in
an increased count of reticulocytes, but is less likely as-
sociated with hearing impairment [12]. This interpret-
ation can also be used for the association of respiratory
distress as a result of severe anemia and hearing loss.
Respiratory distress is correlated with passing the OAE
testing. Height is another factor associated with otologic
impairment. Smaller children have an increased risk ofhearing loss than taller children. On the one hand this
can be linked to the fact that age is a risk factor to de-
velop inner ear impairment, and on the other hand the
height effect can be correlated with the nutrition status
of the children. A poor nutrition status has been associ-
ated with a poor outcome in infectious diseases [29].
A limitation of the study appears to be the lack of
tympanometry as an objective evaluation method of the
outer ear canal and the middle ear. Lee et al. compared
pneumatic otoscopy and tympanometry as tools to diag-
nose otitis media with effusions. With a sensitivity of
97.2 % otoscopy was superior to tympanometry, which
had 87.5 % sensitivity. The gold standard to diagnose
otitis media with effusions would be otomicroscopy with
a sensitivity of 100 %. Ear microscopy was not available
in the study setting. Therefore the better method of the
remaining two was used [30]. OAE testing is an object-
ive method to evaluate inner ear function. With a sensi-
tivity of 93 % and a specificity of 67 %, detecting a
hearing loss of 30 dB or more is very likely; nevertheless,
false positive and false negative results cannot be ex-
cluded [17]. Using the identical operators and OAE ma-
chine to recruit the control group and the malaria
groups suggests an equal failure rate in both groups,
thus not influencing the study result. A possible limita-
tion arises from the control group. Healthy children
were recruited at the three study sites outside the hos-
pital. A medical history of hearing problems and of hos-
pital admission due to fever, which could be linked to
hearing impairment [18], were exclusion criteria for the
control group. However, OAE testing in a comparable
setting in the US showed an identical passing percentage
[24]. A further possible bias was the loss to follow-up of
78 patients, which is more than 50 %. Interestingly, all
patients with cerebral malaria patients were included in
the last follow-up examination, whereas only 48 patients
of the severe malaria group showed up for the last
examination. Assuming that individuals in good condi-
tions are more likely to miss a physician appointment,
this could be a bias. Nevertheless with all patients with
cerebral malaria included, this possible limitation does
not account for the cerebral malaria group. A further
limitation of the study is the comparably short follow-up
period of only 28 days: a long-time effect on the func-
tion of the inner ear cannot be reported. Additionally, a
further audiologic evaluation of the patients with failed
OAE would be necessary to provide final objective evi-
dence of the resulting functional impairment. More
studies will be necessary, including a longer follow-up
period and additional audiologic evaluations, like audi-
tory evoked brainstem responses. Another limitation of
the study is that not all patients could be included at the
baseline measurement. When dealing with children who
were potentially fatally ill, the primary therapy was not
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admissions). Therefore, quite a number of patients missed
the first measurement.
The fundamental pathologic cause of malaria-induced
hearing loss is not fully understood. Severe malaria ani-
mal models have detected induction of apoptosis in the
fibrocytes of the spiral ligament [12], in which the blood
labyrinth barrier is positioned. Evans blue staining of the
“malaria infected cochlea” has shown a breakdown of
the blood labyrinth barrier, influencing the electrolyte
circulation of the cochlea [12]. The fact that cerebral
malaria is more likely to cause failure of OAE might be
explained by the elevated intracranial pressure associated
with cerebral malaria [31]. Elevated pressure to the
cochlea, originating from the intracranial space has been
suspected to cause cochlea damage [32]. Vice versa, the
release of intracranial pressure has been associated with
an improvement of the OAE [33]. Further in vivo animal
studies are required.
Conclusion
The present data show that severe malaria and cerebral
malaria lead to a cochlea malfunction of 20 dB or more
in > 40 % of patients. With 240 million cases per year,
only a small percentage of individuals with persistent
hearing impairment still results in a huge number of dis-
abled individuals, with enormous developmental and so-
cioeconomic impact [34]. These data should increase
awareness that malaria may lead to hearing impairment
in children. Hearing screening should become a standard
examination after malaria infection in children.
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